The epithelial-mesenchymal transition (EMT, 상피간엽이행) is a process by which epithelial cells lose their cell polarity and cell-cell adhesion, and gain migratory and invasive properties to become mesenchymal stem cells. (from Wikipedia)
These are multipotent stromal cells that can differentiate into a variety of cell types. EMT is essential for numerous developmental processes including Mesoderm formation and Neural tube formation. EMT has also been shown to occur in wound healing, in organ Fibrosis and in the initiation of Metastasis for Cancer progression.
특징
- Cell adhesion을 잃고
- 모양이 길쭉해짐
- Cancer stem cell의 특징을 가짐
마커
- Epithelial: E-cadherin
- Mesenchymal: SNAIL1, SNAIL2,...
관련 전사인자
Patyway
Role of Epithelial–mesenchymal transition (EMT) during cancer progression
- Assigning stem cell characteristics to didifferentiated tumor cells
- Redifine resident genetically altered stem cells to be Cancer stem cells
- The dissemination of thmor cells from the Solid tumor and subsequent migration
- Ready to move towards Metastasis
- Further promote resistance to tumor therapy, leading to recurrence and poor prognosis
관련정보
Table of Contents
Incoming Links #
Related Medical Scholarly Articles (MedicalScholarlyArticle 0) #
- Biomarkers in triple negative breast cancer: A review
- DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression
- Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype
- Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
- klzzwxh:0050
- Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis
Related Drugs (Drug 1) #
Related Articles (Article 2) #
Related Books (Book 3) #
Related Medical Conditions (MedicalCondition 4) #
Suggested Pages #
- 0.449 Metastasis
- 0.195 Helicobacter pylori
- 0.090 CDH1
- 0.066 Neoplasm
- 0.052 Triple-negative breast cancer
- 0.024 Cancer
- 0.020 TP53
- 0.019 Heparan sulfate
- 0.013 Lung cancer
- 0.010 Comparative genomic hybridization
- More suggestions...